Ceftriaxone/cefetametpivoxil versus cefuroxime/cefuroxime axetil. Pharmacoeconomic comparison of sequential intravenous/oral therapy in patients with community acquired pneumonia;Ceftriaxon i.v./cefetametpivoxil versus cefuroxim i.v./cefuroximaxetil. Pharmakookonomischer vergleich der intravenos-oralen sequenzialtherapie bei patienten mit ambulant erworbener pneumonie

Chemotherapie Journal

Volumn 9, Issue 2, 2000, Pages 87-92

  Stille, W ^a   Sass, R ^a   Klinge, R ^a   Loos, U ^a   Althoff, P H ^a   Kullmann, K H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cefetametpivoxil; Ceftriaxone; Cefuroxime; Cefuroxime axetil; Pharmacoeconomy; Pneumonia; Sequential therapy

Indexed keywords

CEFETAMET PIVOXIL; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THORAX RADIOGRAPHY;

EID: 0034101703     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)